Abstract | OBJECTIVE: METHODS: One hundred and thirty-one patients with AIE were recruited retrospectively across 7 hospitals. Clinical data were collected during admission and at 12 months. EEGs were reviewed using a standard reporting proforma. Associations between EEG biomarkers, AIE subtypes, and clinical outcomes were assessed using logistic regression modeling. RESULTS: Presence of superimposed fast activity (OR 34.33; 95% CI 3.90, 4527.27; p < 0.001), fluctuating EEG abnormality (OR 6.60; 95% CI 1.60, 37.59; p = 0.008), and hemispheric focality (OR 28.48; 95% CI 3.14, 3773.14; p < 0.001) were significantly more common in N-methyl-d-aspartate receptor (NMDAR) antibody-associated patients with AIE compared to other AIE subtypes. Abnormal background rhythm was associated with a poor mRS (modified Rankin score) at discharge (OR 0.29; 95% CI 0.10, 0.75; p = 0.01) and improvement in mRS at 12 months compared with admission mRS (3.72; 95% CI 1.14, 15.23; p = 0.04). SIGNIFICANCE: We have identified EEG biomarkers that differentiate NMDAR AIE from other subtypes. We have also demonstrated EEG biomarkers that are associated with poor functional outcomes.
|
Authors | Robb Wesselingh, James Broadley, Katherine Buzzard, David Tarlinton, Udaya Seneviratne, Chris Kyndt, Jim Stankovich, Paul Sanfilippo, Cassie Nesbitt, Wendyl D'Souza, Richard Macdonell, Helmut Butzkueven, Terence J O'Brien, Mastura Monif |
Journal | Epilepsy & behavior : E&B
(Epilepsy Behav)
Vol. 128
Pg. 108571
(03 2022)
ISSN: 1525-5069 [Electronic] United States |
PMID | 35101840
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2022 Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis
(complications)
- Biomarkers
- Electroencephalography
- Hashimoto Disease
(complications, diagnosis)
- Humans
- Retrospective Studies
|